Spain Moves Closer to Medical Cannabis Regulation
Spain is on the verge of implementing long-awaited regulations for medical cannabis, with the government expected, at the time of writing, to approve a royal decree before the summer of 2025. This development follows years of debate and gradual progress in formalising a regulated medical cannabis industry within the country.
Government Steps Toward Regulation
The regulatory process formally began in February 2024, when Spain's Ministry of Health started work on a royal decree to regulate medical cannabis and invited public input. The Ministry then prepared a draft royal decree outlining a structured approach to medical cannabis use.
According to reports in January 2025, the draft has been sent to the European Commission. Under the EU notification procedure for draft technical regulations, this generally means waiting three months before adoption, during which the Commission and other Member States can comment; it is not an approval by the Commission. After that, the Council of State is expected to give its opinion before the government adopts the decree.
The proposed decree aims to establish a controlled medical cannabis framework, detailing its use for specific conditions. According to the Ministry, this would bring Spain closer to countries such as Portugal, the United Kingdom and Norway, which already have rules allowing the medical use of cannabis.
Who Will Benefit From the New Regulations?
According to reports on the draft, it defines the conditions for which standardised cannabis preparations could be prescribed, based on existing scientific research. These include:
- Multiple sclerosis – for managing stiffness and muscle spasms.
- Severe forms of refractory epilepsy – cases that do not respond to conventional treatments.
- Nausea and vomiting caused by chemotherapy.
- Refractory chronic pain – persistent pain that remains unmanageable with standard treatments.
Spain's Ministry of Health describes the regulation as rigorous and based on the best available scientific evidence, and says it will be evaluated periodically.
Ensuring Safety and Quality
The Spanish Ministry of Health has said that the proposed framework is designed with safeguards for product quality and patient safety, although quality standards do not by themselves rule out side effects or other risks for patients. The regulation would provide a legal route to standardised cannabis preparations which, according to reports on the draft, would be prepared as magistral formulas and dispensed through hospital pharmacies.
The Ministry also says the framework is designed to evolve as more information becomes available, and reports on the draft indicate that the list of conditions could be expanded on the basis of new scientific findings.
Personal Perspective
Despite the lack of formal regulations, Spain has had an active cannabis industry for years, with many patients relying on unofficial sources. A regulated system could provide quality-controlled options for patients and also create a structured environment for businesses and investors.
Spain has a strong presence in the global cannabis landscape, yet its domestic policies have lagged behind other European nations.
Establishing a regulated framework could help improve patient safety and also position Spain as a key player in the legal cannabis industry. If implemented correctly, this regulation could set the stage for broader policy discussions, possibly leading to more comprehensive cannabis laws in the future.
